Journal of Traditional Chinese Medicine >
Neuroprotective effect of Naochuxue prescription (脑出血方) on intracerebral hemorrhage: inhibition of autophagy via downregulating high mobility group box-1
Received date: 2023-03-22
Accepted date: 2023-09-05
Online published: 2024-05-15
Supported by
Study on the Mechanism of Cerebral Hematoma Resorption by Intervening Cerebral Hemorrhage Prescription based on the Method of Breaking Blood and Removing Blood Stasis(81774224);Anti-inflammatory Mechanism of Naochuxue Prescription based on Toll-like Receptor 4/AKT/Forkhead Box O3 Pathway Regulation of Microglia Autophagy(2021JC070)
OBJECTIVE: To determine the molecular mechanisms underlying the neuroprotective effects of Naochuxue prescription (脑出血方,NCXP) in rats with intracerebral hemorrhage (ICH).
METHODS: Sprague-Dawley rats were injected with collagenase to generate ICH models, which were then randomly divided into six groups, including control, sham, model, and three intervention groups. The intervention groups received different doses of NCXP (0.13, 0.26, and 0.52 g/kg) daily for 10 d. High-performance liquid chromatography (HPLC) was used to analyze the chemical characteristics of NCXP. The neurobehavioral outcomes of the rats were evaluated using neurological deficit scores (Zea Longa 5) and the corner turn test. Pathomorphological changes in perihematomal tissues after ICH were observed using hematoxylin and eosin staining. Immunohistochemistry (IHC) was used to detect the inflammation expression of interleukin 6 (IL-6) and toll-like receptor 4 (TLR4). High mobility group box-1 (HMGB1), Beclin1, microtubule-associated protein 1 light chain 3 beta (LC3), and sequestosome 1 (p62) were detected using real-time quantitative polymerase chain reaction and Western blotting in perihematomal tissues.
RESULTS: HPLC showed that the NCXP had good stability. Rats with ICH had severe neurological function deficits compared to the control group. IHC results showed that NCXP significantly downregulated the expression of the inflammatory proteins IL-6 and TLR4. ICH rats treated with NCXP showed less neurological injury than the model group, accompanied by a significantly decreased expression of HMGB1, Beclin1, and LC3 and an increased expression of p62.
CONCLUSIONS: The neuroprotective effect of NCXP alleviated inflammation and autophagy possibly by downregulating HMGB1 expression. However, further research on the signaling pathways is required to verify this hypothesis.
Hong JIN , Xinna WANG , Ruonan WANG , Jinjian LI , Junchao YU , Dexi ZHAO , Lu ZHAI . Neuroprotective effect of Naochuxue prescription (脑出血方) on intracerebral hemorrhage: inhibition of autophagy via downregulating high mobility group box-1[J]. Journal of Traditional Chinese Medicine, 2024 , 44(5) : 944 -953 . DOI: 10.19852/j.cnki.jtcm.20240515.003
| 1. | Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 2013; 1: e259-81. |
| 2. | Li X, Huang X, Tang Y, et al. Assessing the pharmacological and therapeutic efficacy of Traditional Chinese Medicine Liangxue Tongyu prescription for intracerebral hemorrhagic stroke in neurological disease models. Front Pharmacol 2018; 9: 1169. |
| 3. | Rodriguez-Luna D, Stewart T, Dowlatshahi D, et al. Perihematomal edema is greater in the presence of a spot sign but does not predict intracerebral hematoma expansion. Stroke 2016; 47: 350-55. |
| 4. | Dang G, Yang Y, Wu G, Hua Y, Keep RF, Xi G. Early erythrolysis in the hematoma after experimental intracerebral hemorrhage. Transl Stroke Res 2017; 8: 174-82. |
| 5. | Babi MA, James ML. Peri-hemorrhagic edema and secondary hematoma expansion after intracerebral hemorrhage: from benchwork to practical aspects. Front Neurol 2017; 8: 4. |
| 6. | Mendelow A, Gregson B, Fernandes H, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387-97. |
| 7. | Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH Ⅱ): a randomised trial. Lancet 2013; 382: 397-408. |
| 8. | Zhao D, Yu L. Clinical study on the treatment of hemorrhagic stroke based on the method of “breaking blood and resolving blood stasis". Changchun Zhong Yi Yao Da Xue Xue Bao 2012; 28: 974-75. |
| 9. | Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke 2020; 22: 29-46. |
| 10. | Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139-62. |
| 11. | Shen X, Ma L, Dong W, et al. Autophagy regulates intracerebral hemorrhage induced neural damage via apoptosis and NF-κB pathway. Neurochem Int 2016; 96: 100-12. |
| 12. | Li H, Wu J, Shen H, et al. Autophagy in hemorrhagic stroke: mechanisms and clinical implications. Prog Neurobiol 2018; 163-4: 79-97. |
| 13. | Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571-80. |
| 14. | Tang D, Kang R, Livesey KM, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-92. |
| 15. | Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990; 21: 801-7. |
| 16. | Fang H, Chen J, Lin S, et al. CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling. J Immunol 2014; 192: 5984-92. |
| 17. | Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91. |
| 18. | Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002; 33: 2478-84. |
| 19. | Lin W, Hou J, Han T, Zheng L, Liang H, Zhou X. Efficacy and safety of Traditional Chinese Medicine for intracranial hemorrhage by promoting blood circulation and removing blood stasis: a systematic review and Meta-analysis of randomized controlled trials. Front Pharmacol 2022; 13: 942657. |
| 20. | Li HQ, Wei JJ, Xia W, et al. Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and Meta-analysis. Acta Pharmacol Sin 2015; 36: 659-75. |
| 21. | Zeng L, Tang G, Wang J, et al. Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial. BMJ Open 2019; 9: e024932. |
| 22. | Liu H, Ren J, Wang J, et al. Pharmacoeconomic evaluation of herbal decoctions for activating blood circulation to remove blood stasis and filling essence and nourishing marrow to treat cerebral hemorrhage at the acute stage. Beijing Zhong Yi Yao 2015; 34: 513-16. |
| 23. | Ma Y, Zhang D, Lyu Z, et al. Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: a randomized placebo-controlled trial. Medicine 2021; 100: e24214. |
| 24. | Ren J, Zhou X, Wang J, Zhao J, Zhang P. Poxue Huayu and Tianjing Busui decoction for cerebral hemorrhage (upregulation of neurotrophic factor expression): upregulation of neurotrophic factor expression. Neural Regen Res 2013; 8: 2039-49. |
| 25. | Dong H, Ren JX, Wang JJ, et al. Chinese medicinal leech: ethnopharmacology, phytochemistry, and pharmacological activities. Evid Based Complement Alternat Med 2016; 2016: 1-11. |
| 26. | Komatsu K, Nagayama Y, Tanaka K, Ling Y, Basnet P, Meselhy MR. Development of a high performance liquid chromatographic method for systematic quantitative analysis of chemical constituents in rhubarb. Chem Pharm Bull 2006; 54: 941-7. |
| 27. | Hu B, Zhang H, Meng X, Wang F, Wang P. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol 2014; 153: 846-53. |
| 28. | Zeng P, Wang XM, Su HF, et al. Protective effects of Da-cheng-qi decoction in rats with intracerebral hemorrhage. Phytomedicine 2021; 90: 153630. |
| 29. | Jadaun KS, Mehan S, Sharma A, Siddiqui EM, Kumar S, Alsuhaymi N. Neuroprotective effect of Chrysophanol as a PI3K/AKT/mTOR signaling inhibitor in an experimental model of autologous blood-induced intracerebral hemorrhage. Curr Med Sci 2022; 42: 249-66. |
| 30. | Feng L, Li M, Ren J, et al. Proteomic analysis reveals that Di Dang decoction protects against acute intracerebral hemorrhage stroke in rats by regulating S100a8, S100a9 Col1a1, and Col1a2. Neuropsychiatr Dis Treat 2021; 17: 3301-14. |
| 31. | Luo L, Wu S, Chen R, Rao H, Peng W, Su W. The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice. Chin Med 2020; 15: 119. |
| 32. | Yang ZQ, Zhao DX. Discussion on the mechanism of cerebral hemorrhage recipe on cerebral hemorrhage treatment based on network pharmacology. Jilin Zhong Yi Yao 2021; 41: 363-7. |
| 33. | Yang Z, Liu B, Zhong L, et al. Toll-like receptor-4-mediated autophagy contributes to microglial activation and inflammatory injury in mouse models of intracerebral haemorrhage: TLR4-mediated microglial autophagy. Neuropathol Appl Neurobiol 2015; 41: e95-106. |
| 34. | Tian X, Sun L, Feng D, et al. HMGB1 promotes neurovascular remodeling via rage in the late phase of subarachnoid hemorrhage. Brain Research 2017; 1670: 135-45. |
| 35. | Bahadar GA, Shah ZA. Intracerebral hemorrhage and diabetes mellitus: blood-brain barrier disruption, pathophysiology and cognitive impairments. CNS Neurol Disord Drug Targets 2021; 20: 312-26. |
| 36. | Lei C, Geng J, Zhong L. The association between plasma HMGB1 and sRAGE and clinical outcome in intracerebral hemorrhage. J Neuroimmunol 2020; 345: 577266. |
| 37. | Liu RY, Wang JJ, Qiu X, Wu JM. Acute hyperglycemia together with hematoma of high-glucose blood exacerbates neurological injury in a rat model of intracerebral hemorrhage. Neurosci Bull 2014; 30: 90-8. |
| 38. | He Y, Wan S, Hua Y, Keep RF, Xi G. Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 2008; 28: 897-905. |
| 39. | Xiao H, Chen H, Jiang R, et al. NLRP6 contributes to inflammation and brain injury following intracerebral haemorrhage by activating autophagy. J Mol Med 2020; 98: 1319-31. |
| 40. | Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci 2017; 18: 1865. |
| 41. | Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 2021; 17: 1-382. |
| 42. | Shi H, Wang J, Wang J, Huang Z, Yang Z. IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage. J Neuroimmunol 2018; 323: 143-51. |
| 43. | Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-35. |
| 44. | Lei C, Li Y, Zhu X, Li H, Chang X. HMGB1/TLR4 induces autophagy and promotes neuroinflammation after intracerebral hemorrhage. Brain Res 2022; 1792: 148003. |
| 45. | Durocher M, Knepp B, Yee A, et al. Molecular correlates of hemorrhage and edema volumes following human intracerebral hemorrhage implicate inflammation, autophagy, mRNA splicing, and T cell receptor signaling. Transl Stroke Res 2021; 12: 754-77. |
/
| 〈 |
|
〉 |